Comparer des méthodes

	FACT-Prostate : Évaluation Fonctionnelle des Thérapies contre le Cancer	FACT-Ovarian : Évaluation fonctionnelle des thérapies anticancéreuses
Domaine	Oncologie	Oncologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	1997	2001
Auteur d'origine	Esper, P., et al. (built on Cella, D. F. FACT-G framework)	Basen-Engquist, K., et al. (built on Cella, D. F. FACT-G framework)
Type	Self-report questionnaire	Self-report questionnaire
Source fondatrice	Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J. (1997). Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate instrument. Urology, 50(6), 920–928.	Basen-Engquist, K., Bodurka, D. C., Lu, H., Sill, M. W., Thaker, P. H., Deavers, M. T., et al. (2001). Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) quality of life instrument. Gynecol Oncol, 89(3), 478–488.
Alias	FACT-P	FACT-O
Apparentées	5	5
Résumé	The FACT-Prostate (FACT-P) is a disease-specific quality-of-life instrument for men with prostate cancer, combining the 27-item FACT-G core with a 12-item prostate-specific subscale addressing urinary, sexual, and bowel function concerns. Developed and validated by Esper et al. in 1997, it is a standard outcome measure in prostate cancer clinical trials and clinical practice.	The FACT-Ovarian (FACT-O) is a disease-specific quality-of-life measure for women with ovarian cancer, integrating the 27-item FACT-G core with a 12-item ovarian-specific subscale addressing cancer-related symptoms, sexual function, abdominal distension, and treatment side effects. Validated by Basen-Engquist et al. in 2001, it is a standard endpoint in ovarian cancer clinical trials and supportive care research.